Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,345-1,356 of 4,306
Drug study icon
CompletedNCT00222235

Adjunctive Treatment for Decreasing Symptoms of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Los Angeles
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 54 Years
Countries
United States, Israel
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Behavioral study icon
CompletedNCT01822418

Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)

This summary needs review. Please check the official study record and contact the research team for details.

In Mannheim
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, DepressionBehavioralFrom 18 Years to 60 Years
Countries
Germany
Sponsor
Central Institute of Mental Health, Mannheim
Condition
Schizophrenia, Depression
Drug study icon
CompletedNCT00269919

Long-Term Risperidone Microspheres for schizophrenia

This study is completed in South Korea. It is testing Long-Term Risperidone Microspheres for schizophrenia.

In Seoul
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
South Korea
Sponsor
Janssen Korea, Ltd., Korea
Condition
Schizophrenia
Other study type icon
CompletedNCT01309373

Psychosocial and Symptomatic Remission and Community Integration Status for schizophrenia

This study is completed. It is testing psychosocial and Symptomatic Remission and Community Integration Status for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
Sponsor
Janssen-Cilag, S.A.
Condition
Schizophrenia
Drug study icon
TerminatedNCT00715377

Anticholinergic Burden in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 50 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Drug study icon
TerminatedNCT01913327

Antipsychotic Effects on Brain Function in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In San Francisco
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 40 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Schizophrenia
Other study type icon
CompletedNCT00753506

Artemisinin to Reduce The Symptoms of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Towson
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sheppard Pratt Health System
Condition
Schizophrenia
Drug study icon
TerminatedNCT01929889

Assessing the Effects of Fanapt® on Social Cognition in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Chicago
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Northwestern University
Condition
Schizophrenia
Drug study icon
CompletedNCT00688324

Biomarker Study of Acamprosate in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Baltimore
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Other study type icon
CompletedNCT02033382

Biomarkers in First Episode Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalFrom 16 Years to 40 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.